BEIJING--June 4, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Chinese pharmaceutical company Walvax Biotechnology Company Limited recently was approved to perform clinical trials for its recombinant coronavirus vaccine, according to Chinese National Medical Products Administration. To date, 640 million Chinese citizens have received a vaccine for COVID-19.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
